Literature DB >> 33520052

Prevalence of extended-spectrum β-lactamase (ESBL) and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Enterobacteriaceae isolates from patients in Khartoum, Sudan.

Maha Hassan Dirar1, Naser Eldin Bilal1, Mutasim Elhadi Ibrahim2, Mohamed Elamin Hamid3.   

Abstract

INTRODUCTION: the emergence of antibiotic resistance pathogens is an important health risk. Usually Gram negative bacteria acquire resistance to beta-lactam antibiotics by beta-lactamase production. The objectives of this study was to assess the prevalence of ESBL and to detect the frequency of blaTEM, blaSHV and blaCTX-M genotypes among ESBL producing Enterobacteriaceae isolates from patients in Khartoum, Sudan.
METHODS: a total of 171 isolates of Enterobacteriaceae were recovered from hospitals in Khartoum, Sudan (2014 -2015) were used to detect ESBL production using disc diffusion method. blaTEM, blaSHV and blaCTX-M genes were investigated by PCR based methods using gene-specific primers.
RESULTS: the high resistance among Enterobacteriaceae was noticed in ciprofloxacin (72%) and ofloxacin (73%). ESBL production was mainly in Escherichia Coli (38%) and Klebsiella pneumonia (34%). Prevalent genotypes were blaTEM (86%), blaCTX-M (78%) and blaSHV (28%). These were found mainly in Escherichia Coli (38%, 37%, 2%) and K. pneumonia (34%, 31%, 26.1%). The majority of ESBL producing isolates possess more than one ESBL genes.
CONCLUSION: the ESBL production in Enterobacteriaceae was high, with blaTEM and blaCTX-M genotypes more prevalent. Public health and laboratory standard of excellence is needed to reducing the spread of resistant pathogens. Copyright: Maha Hassan Dirar et al.

Entities:  

Keywords:  Antimicrobial resistance; Escherichia coli; Gram negative bacteria; Klebsiella pneumoniae; genotyping

Mesh:

Substances:

Year:  2020        PMID: 33520052      PMCID: PMC7821812          DOI: 10.11604/pamj.2020.37.213.24988

Source DB:  PubMed          Journal:  Pan Afr Med J


  22 in total

1.  Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.

Authors:  E Vercauteren; P Descheemaeker; M Ieven; C C Sanders; H Goossens
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 2.  Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa.

Authors:  S A Sangare; A I Maiga; I Guindo; A Maiga; N Camara; S Savadogo; S Diallo; F Bougoudogo; L Armand-Lefevre; A Andremont; I I Maiga
Journal:  Med Mal Infect       Date:  2015-09       Impact factor: 2.152

Review 3.  Extended-spectrum cephalosporinases: structure, detection and epidemiology.

Authors:  Patrice Nordmann; Hedi Mammeri
Journal:  Future Microbiol       Date:  2007-06       Impact factor: 3.165

Review 4.  Prevalence and clonality of extended-spectrum beta-lactamases in Asia.

Authors:  P M Hawkey
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

5.  Molecular characterisation of extended-spectrum β-lactamase-producing Gram-negative bacterial isolates from surgical wounds of patients at a hospital in North Central Nigeria.

Authors:  Ahmed Olowo-Okere; Yakubu Kokori Enevene Ibrahim; Busayo Olalekan Olayinka
Journal:  J Glob Antimicrob Resist       Date:  2018-02-10       Impact factor: 4.035

6.  Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing enterobacteriaceae in the community.

Authors:  Daniel Maina; Gunturu Revathi; Samuel Kariuki; Hastings Ozwara
Journal:  J Infect Dev Ctries       Date:  2012-06-15       Impact factor: 0.968

Review 7.  Therapeutic challenges associated with extended-spectrum, beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Authors:  A Wong-Beringer
Journal:  Pharmacotherapy       Date:  2001-05       Impact factor: 4.705

Review 8.  Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices.

Authors:  Johann D D Pitout
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

Review 9.  Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.

Authors:  Enrico Maria Trecarichi; Roberto Cauda; Mario Tumbarello
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

10.  Prevalence of Extended-spectrum β-Lactamases-producing Escherichia coli from Hospitals in Khartoum State, Sudan.

Authors:  Mutasim E Ibrahim; Naser E Bilal; Magzoub A Magzoub; Mohamed E Hamid
Journal:  Oman Med J       Date:  2013-03
View more
  5 in total

1.  Emergence of bla TEM, bla CTX-M, bla SHV and bla OXA genes in multidrug-resistant Enterobacteriaceae and Acinetobacter baumannii in Saudi Arabia.

Authors:  Mutasim E Ibrahim; Tarig B Algak; Mohammed Abbas; Bahaeldin K Elamin
Journal:  Exp Ther Med       Date:  2021-10-14       Impact factor: 2.751

2.  Genetic diversity and multidrug resistance of phylogenic groups B2 and D in InPEC and ExPEC isolated from chickens in Central China.

Authors:  Qin Lu; Wenting Zhang; Ling Luo; Honglin Wang; Huabin Shao; Tengfei Zhang; Qingping Luo
Journal:  BMC Microbiol       Date:  2022-02-18       Impact factor: 3.605

3.  Molecular Epidemiology of Extended-Spectrum Beta-Lactamase and AmpC Producing Enterobacteriaceae among Sepsis Patients in Ethiopia: A Prospective Multicenter Study.

Authors:  Melese Hailu Legese; Daniel Asrat; Abraham Aseffa; Badrul Hasan; Adane Mihret; Göte Swedberg
Journal:  Antibiotics (Basel)       Date:  2022-01-19

4.  Genomic Characterization of International High-Risk Clone ST410 Escherichia coli Co-Harboring ESBL-Encoding Genes and blaNDM-5 on IncFIA/IncFIB/IncFII/IncQ1 Multireplicon Plasmid and Carrying a Chromosome-Borne blaCMY-2 from Egypt.

Authors:  Nelly M Mohamed; Azza S Zakaria; Eva A Edward
Journal:  Antibiotics (Basel)       Date:  2022-07-30

5.  Phylogeny and antimicrobial resistance of extended-spectrum beta-lactamaseproducing Escherichia coli from hospitalized oncology patients in Perú

Authors:  Jose Matta-Chuquisapon; Esther Valencia-Bazalar; Carlos Sevilla-Andrade; Helí Jaime Barrón-Pastor
Journal:  Biomedica       Date:  2022-09-02       Impact factor: 1.173

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.